Cue Biopharma Correlations

CUE Stock  USD 0.96  0.01  1.03%   
The current 90-days correlation between Cue Biopharma and Coya Therapeutics, Common is 0.16 (i.e., Average diversification). The correlation of Cue Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cue Biopharma Correlation With Market

Significant diversification

The correlation between Cue Biopharma and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cue Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
For information on how to trade Cue Stock refer to our How to Trade Cue Stock guide.

Moving together with Cue Stock

  0.91VOR Vor BiopharmaPairCorr
  0.65ELMD Electromed Potential GrowthPairCorr
  0.7INGN Inogen IncPairCorr
  0.67NPCE NeuropacePairCorr
  0.63RKV Rakovina TherapeuticsPairCorr

Moving against Cue Stock

  0.35CMRX ChimerixPairCorr
  0.66NHNCF NAVER CorpPairCorr
  0.54PKX POSCO HoldingsPairCorr
  0.43GCPEF GCL Poly EnergyPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
INMBANIX
INMBLTRN
FENCCOYA
INMBCOYA
FENCLTRN
ANIXCOYA
  
High negative correlations   
PYPDFENC
PYPDCOYA
XFORCOYA
PYPDINMB
XFORINMB
XFORANIX

Risk-Adjusted Indicators

There is a big difference between Cue Stock performing well and Cue Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cue Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
COYA  3.12  0.51  0.13  0.39  3.28 
 8.23 
 20.41 
LTRN  4.65  0.12  0.03  0.31  4.97 
 12.03 
 44.50 
FENC  2.06  0.25  0.08  0.12  2.89 
 4.75 
 16.33 
ELYM  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ANIX  3.39  0.43  0.10  0.39  3.73 
 7.14 
 26.44 
INMB  4.83  1.17  0.25 (1.17) 4.26 
 12.97 
 28.67 
INAB  4.86 (0.18) 0.00 (0.29) 0.00 
 11.54 
 32.12 
PYPD  3.67 (0.12) 0.00  0.08  0.00 
 5.74 
 33.58 
XFOR  6.69 (0.86) 0.00 (2.29) 0.00 
 11.67 
 68.45 
GRTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Cue Biopharma Corporate Management

MSE JDGeneral VPProfile
JD MScCEO DirectorProfile
Kenneth MDActing OfficerProfile
Dr IIICoFounderProfile
Lucinda WarrenChief OfficerProfile
KerriAnn CPAChief OfficerProfile